What is Summit Therapeutics's compensation and benefits?

Summit Therapeutics (SMMT) reported compensation and benefits of $1.88M in Q2 2023.

How has Summit Therapeutics's compensation and benefits changed year-over-year?

Summit Therapeutics's compensation and benefits decreased by 24.9% year-over-year, from $2.5M to $1.88M.

Summit Therapeutics SMMT Compensation and benefits

Discontinued — last reported Q2 '23

Compensation and benefits at other companies

Jazz PharmaceuticalsJAZZ

$74.5M+10.0%

BiogenBIIB

——

Segments

By segment

See full

Reportable Segment$72.79M+556%

Other financials

Income statement

See full

Revenue-—

Operating income-$65.6M-81.2%

Net income-$189.4M-201%

EPS (diluted)-$0.24-167%

Balance sheet

See full

Cash & equivalents$8.2M+7.2%

Total debt$20.0M+211%

Total equity$545.9M+58.5%

Total assets$647.9M+68.8%

Cash flow

See full

Operating cash flow-$122.3M-99.9%

CapEx$245.0K-41.9%

Free cash flow-$122.5M-99.0%

Valuation

See full

Market cap$10.67B+3.3%

Enterprise value$10.68B+3.4%

Profitability

See full

Operating margin-268,266.8%-272,316pp

Net margin-271,685%-275,966pp

FCF margin-5,931.6%+4,730pp

Returns & leverage

See full

Return on equity-271%-1,725pp

Debt / equity0×0.0×

Current ratio7.4×-3.2×

Where this comes from

Reported directly by Summit Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Summit Therapeutics’s 10-Q, filed August 9, 2023, on SEC EDGAR. View the filing →

Ask your AI about Summit Therapeutics's compensation and benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Summit Therapeutics's compensation and benefits?: Summit Therapeutics (SMMT) reported compensation and benefits of $1.88M in Q2 2023.
How has Summit Therapeutics's compensation and benefits changed year-over-year?: Summit Therapeutics's compensation and benefits decreased by 24.9% year-over-year, from $2.5M to $1.88M.